Week 10 HW: Advanced Imaging & Measurement Technology
Final Project
Please identify at least one (ideally many) aspect(s) of your project that you will measure. It could be the mass or sequence of a protein, the presence, absence, or quantity of a biomarker, etc.
- molecular validation (to confirm whether the Twist plasmids are correct and transformed properly) through the presence of the sender and receiver plasmid, correct insert size and sequence identity, then successful bacterial transformation
- functional signalling validation / AHL sensing ability through receiver activation threshold, GFP expression strength, dose-response curve, signal saturation
- spatial pattern formation to measure whether LuxI actually produces AHL through sender-generated AHL activity, effective AHL equivalent concentration, and signalling consistency between cultures
- ML/CAD dataset features through OT-2 plate maps, fluorescence reads, OD600 and metadata logs
Please describe all of the elements you would like to measure, and furthermore, describe how you will perform these measurements. What are the technologies you will use (e.g., gel electrophoresis, DNA sequencing, mass spectrometry, etc.)? Describe in detail.
The project will measure genetic construct integrity, quorum-sensing response strength, sender-derived signalling output, and spatial cellular automata pattern formation.
Plasmid integrity will be measured using colony PCR followed by agarose gel electrophoresis to confirm the expected insert sizes of the LuxI sender and LuxR-sfGFP receiver constructs. Sanger sequencing will then be used to verify promoter-RBS-CDS junctions, spacer regions, stop codons, and inducible promoter elements.
Functional LuxR receiver performance will be quantified by exposing transformed receiver E. coli to a defined dilution series of 3-oxo-C6-HSL and measuring GFP fluorescence over time using a handmade fluorescence plate reader. OD600 measurements will also be collected for normalisation
LuxI sender activity will be measured indirectly by collecting cell-free sender supernatant and applying it to the receiver strain, using the previously generated AHL-GFP calibration curve to infer effective signalling molecule concentration.
Spatial pattern formation relevant to biological cellular automata will be measured using Opentrons OT-2 automated plate layouts combined with fluorescence time-lapse imaging. Metrics including activation radius, propagation velocity, neighbourhood response, and endpoint fluorescence distribution will be extracted and used as training data for ML-enhanced CAD prediction in Aim 2.
Waters Part I — Molecular Weight
- Calculated molecular weight
Compute pI/Mw - Results Theoretical pI/Mw (average)
Sequence: 10 20 30 40 50 60 MVSKGEELFT GVVPILVELD GDVNGHKFSV SGEGEGDATY GKLTLKFICT TGKLPVPWPT
70 80 90 100 110 120
LVTTLTYGVQ CFSRYPDHMK QHDFFKSAMP EGYVQERTIF FKDDGNYKTR AEVKFEGDTL
130 140 150 160 170 180
VNRIELKGID FKEDGNILGH KLEYNYNSHN VYIMADKQKN GIKVNFKIRH NIEDGSVQLA
190 200 210 220 230 240
DHYQQNTPIG DGPVLLPDNH YLSTQSALSK DPNEKRDHMV LLEFVTAAGI TLGMDELYKL
EHHHHHH
Theoretical pI/Mw: 5.90 / 28006.60
2. Calculated molecular weight of the eGFP using the adjacent charge state approach described in the recitation
For my data I chose peaks at $m/z = 933.8044$ and $m/z = 966.0037$
$$966.0037 - 933.8044 = 32.1993$$For $n$ and $n-1$:
$$\frac{MW}{n} - \frac{MW}{n-1} \approx \frac{MW}{n(n-1)}$$$z = 30$ and $z = 29$:
$$\text{Expected spacing} \approx \frac{MW}{30 \times 29} \approx \frac{28000}{870} \approx 32.2$$$m/z = 933.8044$ is $z = 30$
$m/z = 966.0037$ is $z = 29$
MW ($z = 30$):
$$MW = (30 \times 933.8044) - (30 \times 1.007825)$$ $$= 28,014.13 - 30.23$$ $$= 27,983.9\ \text{Da}$$Super close to the theoretical MW of $28,006.60\ \text{Da}$ from the first step
3. accuracy of the measurement using the deconvoluted MW from 2.2 and the predicted weight of the protein from 2.1
$$\text{Accuracy} = \frac{|MW_{\text{experiment}} - MW_{\text{theory}}|}{MW_{\text{theory}}}$$ $$= \frac{|27,983.9 - 28,006.60|}{28,006.60}$$ $$= \frac{22.7}{28,006.60}$$ $$= 0.00081$$ $$= 0.081\%$$Waters Part III — Peptide Mapping - primary structure
1. Lysines (K) and Arginines (R) are in eGFP
K R
MVSKGEELFTG VVPILVELDG DVNGHKFSVS GEGEGDATYGKLTLKFICTT GKLPVPWPTL VTTLTYGVQC FSRYPDHMKQ HDFFKSAMPE GYVQERTIFF KDDGNYKTRA EVKFEGDTLV NRIELKGIDF KEDGNILGHK LEYNYNSHNV YIMADKQKNG IKVNFKIRHN IEDGSVQLAD HYQQNTPIGD GPVLLPDNHY LSTQSALSKD PNEKRDHMVL LEFVTAAGIT LGMDELYKLE HHHHHH
K=20 R=6
2. Peptides generated from tryptic digestion of eGFP?
Theoretical pI: 5.90
Mw (average mass): 28006.60
Mw (monoisotopic mass): 27988.96
| # | Mass | Position | #MC | Modifications | Peptide Sequence |
|---|---|---|---|---|---|
| 1 | 4472.1752 | 170–210 | 0 | HNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSK | |
| 2 | 2566.2931 | 217–239 | 0 | DHMVLLEFVTAAGITLGMDELYK | |
| 3 | 2437.2608 | 5–27 | 0 | GEELFTGVVPILVELDGDVNGHK | |
| 4 | 2378.2577 | 54–74 | 0 | LPVPWPTLVTTLTYGVQCFSR | |
| 5 | 1973.9062 | 142–157 | 0 | LEYNYNSHNVYIMADK | |
| 6 | 1503.6597 | 28–42 | 0 | FSVSGEGEGDATYGK | |
| 7 | 1266.5783 | 87–97 | 0 | SAMPEGYVQER | |
| 8 | 1083.4979 | 240–247 | 0 | LEHHHHHH | |
| 9 | 1050.5214 | 115–123 | 0 | FEGDTLVNR | |
| 10 | 982.4952 | 133–141 | 0 | EDGNILGHK | |
| 11 | 821.3940 | 81–86 | 0 | QHDFFK | |
| 12 | 790.3552 | 75–80 | 0 | YPDHMK | |
| 13 | 769.3913 | 47–53 | 0 | FICTTGK | |
| 14 | 711.2944 | 103–108 | 0 | DDGNYK | |
| 15 | 655.3813 | 98–102 | 0 | TIFFK | |
| 16 | 602.2780 | 211–215 | 0 | DPNEK | |
| 17 | 579.3137 | 128–132 | 0 | GIDFK | |
| 18 | 507.2925 | 164–167 | 0 | VNFK | |
| 19 | 502.3235 | 124–127 | 0 | IELK |
Predicted peptides = 19
- -5.
Observed LC peaks = ~19
Observed peaks are about the same as predicted
Main peptide peak = 525.76712
Spacing = 0.5 m/z, => most abundant charge state is 2+. The singly charged mass is 1050.52 Da
Charge = +2 [ M + H ] + [M+H] + = 1050.52145 Da [ M + H ] + [M+H] + = 1050.52438 Da
Identified peptide: FEGDTLVNR
the error is about 2.8 ppm
- Identify the peptide from PeptideMass
FEGDTLVNR has a theoretical monoisotopic mass of 1050.52143 Da
7. 88 is the percentage of the sequence that is confirmed by peptide mapping
Waters Part IV — Oligomers
7FU Decamer = 3.40 MDa
8FU Didecamer = 8 MDa
8FU 3-Decamer = 12 MDa
8FU 4-Decamer = 16 MDa
Waters Part V — Did I make GFP?
Yes!
| Parameter | Theoretical | Observed/Measured on Intact LC-MS | PPM Mass Error | Molecular Weight (kDa) |
|---|---|---|---|---|
| eGFP Monomer | 26,905 Da | 26,903 Da | 0.7 ppm | 26.90 |